Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2025-12-25 @ 3:37 AM
NCT ID:
NCT03596502
Eligibility Criteria:
Inclusion Criteria:
* Patients with a new prescription for an oral anticoagulant that had a diagnosis of atrial fibrillation or atrial flutter within the 3 years prior to the date of the prescription
* Patients aged 18 years or older (except Alberta, Nova Scotia, and Ontario, where patients will be aged at least 66 years or older)
Exclusion Criteria:
* Patients with less than one year of data availability prior to cohort entry
* Patients with a diagnosis of valvular disease (including rheumatic heart disease) or prior cardiac valve surgery
* Patients with a diagnosis of venous thromboembolic disease in the year prior to cohort entry
* Patients who underwent hemodialysis in the 90 days prior to cohort entry
* Patients with a hip, femur, or knee surgery in the 30 days prior to cohort entry
* Patients with a diagnosis of antiphospholipid syndrome
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03596502
Study Brief:
Protocol Section:
NCT03596502